Abstract:Liver failure is a serious disease that is characterized by global hepatocyte necrosis. Hepatocyte proliferation and liver regeneration are critically important for the success of treatments for liver disease. Tetrahedral framework nucleic acids (TFNAs), which are widely used antioxidants and anti-inflammatory nanomaterials, activate multiple proliferation and prosurvival pathways. Therefore, the effects of a TFNA on hepatocyte proliferation and liver regeneration in mouse livers injured by 70% partial hepatectomy (PHx), acetaminophen overdose, and carbon tetrachloride were explored in this study. The TFNA, which was successfully self-assembled from four specifically designed ssDNAs, entered the body quickly and was taken up effectively by hepatocytes in the liver and could eventually be cleared by the kidneys. The TFNA promoted hepatocyte proliferation in vitro by activating the Notch and Wnt signaling pathways. In the three in vivo mouse models of liver injury, the TFNA attenuated the injuries and enhanced liver regeneration by regulating the cell cycle and the P53 signaling pathway. Therefore, by promoting hepatocyte proliferation and enhancing liver regeneration, the TFNA shows potential as an effective therapeutic agent for treating acute liver injury induced by 70% PHx and other factors, thereby preventing the progression to acute liver failure and reducing the associated mortality rate.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.2c02523.Additional experimental details, materials, and methods, including cell extraction and culture, cell counting kit-8 assay, quantitative polymerase chain reaction, western blot analysis, 5-ethynyl-2′-deoxyuridine assay, mRNA microarray analysis, CK18 immunohistochemical staining, periodic acid–Schiff staining, and hematoxylin and eosin staining; DNA sequences of TFNA; primer sequences of target genes in vitro; primer sequences of target genes in vivo; extraction and identification of mouse primary hepatocytes; proliferation of mouse primary hepatocytes promoted by TFNAs; effects of TFNAs on liver re-growth and liver injury in vivo in CCL4-induced mice models; effects of TFNAs on liver re-growth and liver injury in vivo in CCL4-induced mice models; effects of TFNAs on liver re-growth and liver injury in vivo in APAP-induced mice models; and effects of TFNAs on liver re-growth and liver injury in vivo in APAP-induced mice models (PDF)This article has not yet been cited by other publications.

Mfap4: a promising target for enhanced liver regeneration and chronic liver disease treatment

Apolipoprotein A-1 Accelerated Liver Regeneration Through Regulating Autophagy Via AMPK-ULK1 Pathway.

Synergistic Modulation of a Tunable Microenvironment to Fabricate a Liver Fibrosis Chip for Drug Testing.

Inhibition of wild-type p53-induced phosphatase 1 promotes liver regeneration in mice by direct activation of mammalian target of rapamycin.

Phosphatidic acid-enabled MKL1 contributes to liver regeneration: translational implication in liver failure

Liver Fibrosis Therapy Based on Biomimetic Nanoparticles Which Deplete Activated Hepatic Stellate Cells.

LiverZap: a chemoptogenetic tool for global and locally restricted hepatocyte ablation to study cellular behaviours in liver regeneration

Mitochondria-Regulated Information Processing Nanosystem Promoting Immune Cell Communication for Liver Fibrosis Regression

Targeting Endothelial Erk1/2-Akt Axis As a Regeneration Strategy to Bypass Fibrosis During Chronic Liver Injury in Mice.

Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy

Smart Microneedle Arrays Integrating Cell‐Free Therapy and Nanocatalysis to Treat Liver Fibrosis

Maladaptive regeneration and metabolic dysfunction associated steatotic liver disease: Common mechanisms and potential therapeutic targets

Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA

Advances in the regulation of liver regeneration

PPARα activation promotes liver progenitor cell-mediated liver regeneration by suppressing YAP signaling in zebrafish

Liver Fibrosis: From Pathogenesis to Novel Therapies

MANF serves as a novel hepatocyte factor to promote liver regeneration after 2/3 partial hepatectomy via doubly targeting Wnt/β-catenin signaling

First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure

Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis

Liver fibrosis pathologies and potentials of RNA based therapeutics modalities

Therapeutic Effects of Self-Assembled Tetrahedral Framework Nucleic Acids on Liver Regeneration in Acute Liver Failure